Abstract:Purpose: MicroRNAs (miRNAs) - as negative regulators of target genes - are associated with various human diseases, but their precise role(s) in diabetic retinopathy (DR) remains to be elucidated. The aim of this study was to elucidate the involvement of miRNAs in early DR using in silico analysis to explore their gene expression patterns. Methods: We used the streptozotocin (STZ)-induced diabetic rat to investigate the roles of miRNAs in early DR. Retinal miRNA expression profiles from diabetic versus healthy control rats were examined by miRNA array analysis. Based on several bioinformatic systems, specifically, gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, we identified signatures of the potential pathological processes, gene functions, and signaling pathways that are influenced by dysregulated miRNAs. We used quantitative real-time polymerase chain reaction (qRT-PCR) to validate six (i.e. those with significant changes in expression levels) of the 17 miRNAs that were detected in the miRNA array. We also describe the significant role of the miRNA-gene network, which is based on the interactions between miRNAs and target genes. Results: GO analysis of the 17 miRNAs detected in the miRNA array analysis revealed the most prevalent miRNAs to be those related to biological processes, olfactory bulb development and axonogenesis. These miRNAs also exert significant influence on additional pathways, including the mitogen-activated protein and calcium signaling pathways. Six of the seventeen miRNAs were chosen for qRT-PCR validation. With the exception of a slight difference in miRNA-350, our results are in close agreement with the differential expressions detected by array analysis. Conclusions: This study, which describes miRNA expression during the early developmental phases of DR, revealed extensive miRNA interactions. Based on both their target genes and signaling pathways, we suggest that miRNAs perform critical regulatory functions during the early stages of DR evolution.

Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis.

Altered Microrna Expression Profiles in Retinas with Diabetic Retinopathy.

Differentially Expressed Micrornas in the Development of Early Diabetic Retinopathy

A 3-miRNA Risk Scoring Signature in Early Diabetic Retinopathy

hsa-mir-(4328, 4422, 548z and -628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

RNA-Seq Revealed Novel Non-proliferative Retinopathy Specific Circulating MiRNAs in T2DM Patients.

Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis

Identification of novel key molecular signatures in the pathogenesis of experimental diabetic retinopathy

Integrated bioinformatics analysis for novel miRNAs markers and ceRNA network in diabetic retinopathy

RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.

Advances in Research Related to MicroRNA for Diabetic Retinopathy

MiRNAs Expression Profiles in the Early Stage of Diabetic Mice

Functions of Microrna in Pathogenesis of Diabetic Retinopathy

Integrated Bioinformatic Changes and Analysis of Retina with Time in Diabetic Rats

Identification of Collective Expression Pattern of miRNA in the Regulation of Diabetic Retinopathy

Roles of Mirnas and Long Noncoding RNAs in the Progression of Diabetic Retinopathy

Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas

Integrative Computational Approach Revealed Crucial Genes Associated With Different Stages of Diabetic Retinopathy

Identification Of Altered Micrornas In Retinas Of Mice With Oxygen-Induced Retinopathy

Bioinformatics Analysis of Weighted Genes in Diabetic Retinopathy